- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
Life Science & Biotech
OrthoWorx initiative names executive director
June 3, 2010
IBJ StaffNot-for-profit launched last year by BioCrossroads and Indiana's orthopedic companies names Zimmer Inc. executive Brad Bishop
to lead the initiative.
MoreCancer researcher battling Semafore in court
May 29, 2010
Chris O'MalleyFormer collaborator alleges firm breached its agreement with him and refused to pay royalty income.
MoreBiopharma fueling boom in refrigerated warehousing
May 29, 2010
Chris O'MalleyIn the past few years, a handful of cold storage facilities have sprouted locally by playing to Indianapolis' strengths
in warehousing and life sciences.
MoreIndianapolis startup attacks Alzheimer's disease
May 29, 2010
Norm HeikensAgeneBio Inc. this month landed a $300,000 investment from the Indiana Seed Fund to fund operations, bolster its intellectual
property, and begin learning how to make a drug into a once-a-day pill.
MoreBioanalytical Systems reports loss in second quarter
May 17, 2010
IBJ StaffBioanalytical Systems Inc. narrowed its losses in the second fiscal quarter despite a 2 percent drop in revenue, the West
Lafayette-based contract research firm said late last week.
MoreBioanalytical Systems names new chief executive
May 14, 2010
IBJ StaffWest Lafayette-based Bioanalytical Systems Inc. has promoted Anthony S. Chilton to CEO following the retirement of top executive
Richard M. Shepperd earlier this year.
MoreTAYLOR: Reform will drive demand for health care facilities
May 8, 2010
Deeni TaylorThere has been a noticeable uptick in the level of health care real estate development activity this year.
MoreIndiana's growth in life sciences jobs beats national average
May 8, 2010
IBJ StaffBloomington led the nation as the No. 1 small city in medical devices and equipment.
MoreDow AgroSciences' profit rises despite lower revenue
April 28, 2010
IBJ Staff and Associated PressThe Indianapolis unit of Dow Chemical sees quarterly profit rise 6 percent, to $384 million, despite an 8-percent dip in revenue.
The parent company reports strongest quarterly results in more than a year.
MoreChao exit hurts drug development industry
April 28, 2010
J.K. WallPurdue University’s decision to close the Chao Center in West Lafayette is a setback for Indiana’s effort to grow
a vibrant contract drug manufacturing sector. But it’s just the latest in a series of unexpected changes—not all
for
the worse—since Indianapolis-based BioCrossroads launched a contract drug manufacturing initiative in late 2007.
MoreJudge rejects Guidant's defibrillator plea deal
April 27, 2010
Bloomberg NewsA federal judge has rejected Guidant Corp.'s guilty plea to charges it hid defects in heart defibrillators, after some
doctors and patients complained about the $296 million deal.
MoreMedical device startup FlowCo enlists Guidant alums
April 24, 2010
Chris O'MalleyThe upstart developer of a device to help doctors choose the right-sized stent to prop open clog-prone arteries has brought
aboard former Guidant Corp. executives, including Bill McConnell. Their regulatory and marketing expertise could help FlowCo
Inc. bring its artery-measurement
product to market as soon as 2011.
MoreLilly to pay $400M to repurchase Cymbalta rights
April 19, 2010
Bloomberg NewsEli Lilly and Co. will repurchase rights to develop and market antidepressant Cymbalta outside the U.S. and Japan from European
partner Boehringer Ingelheim for an initial payment of $400 million.
MoreLilly sues Hospira over generic version of Gemzar
March 24, 2010
Bloomberg NewsIndianapolis-based Eli Lilly and Co. sued rival drugmaker Hospira Inc. to prevent it from selling a generic version of the
cancer drug Gemzar before a patent on the medicine expires in 2013.
MoreAriad loses $65M patent appeal against Eli Lilly
March 22, 2010
Bloomberg NewsMonday's decision throws out a $65.2 million patent-infringement verdict won by Ariad for royalties on Lilly's osteoporosis
drug Evista and sepsis medicine Xigris.
MoreFDA says 'not yet' on Lilly's once-weekly Byetta
March 15, 2010
J.K. WallRegulators won't require more time-consuming tests of the drug, but want Eli Lilly and Co. and its partners to clarify labeling,
manufacturing
processes.
MoreEli Lilly to buy European rights to Pfizer animal products
March 8, 2010
Scott OlsonThe acquisition will benefit Elanco, Lilly's animal health division in Greenfield, which has become increasingly important
to Lilly as it braces for patent-protection losses.
MoreDow AgroSciences considered expansion elsewhere
March 5, 2010
Peter SchnitzlerAgricultural biotech firm hired a site-selection consultant and considered other cities around the world for its $340 million
expansion.
MoreDow Agro plans $340M expansion, 577 new jobs
March 4, 2010
Peter SchnitzlerThe investment will greatly expand the company's research and development capacity and is a major win for the Indiana
life sciences industry. Dow AgroSciences expects most of the positions to pay between $65,000 and $95,000 annually.
MoreCornelius to retire as Bristol-Myers Squibb CEO
March 3, 2010
IBJ Staff and Associated PressThe former Guidant Corp. CEO and long-time Eli Lilly exec said he and his family will be returning to Indianapolis.
MoreDow Agro plans 'major' expansion announcement
March 3, 2010
Peter SchnitzlerLocal Dow Chemical subsidiary expects to launch five new biotech products by 2012.
MoreLilly to shift more employees to Covance
February 26, 2010
J.K. WallGreenfield Labs operation expects to add 17 Eli Lilly and Co. workers after taking over staff of 264 in 2008 acquisition.
MoreIndiana companies that serve pharmaceutical industry grew in 2009
February 20, 2010
IBJ StaffThe firms continued to grow over the last year but face increasing challenges, according to a new report by Indianapolis-based
life sciences trade group BioCrossroads.
MoreVortek Surgical moving HQ to Brownsburg, adding 60 jobs
February 18, 2010
IBJ StaffIndianapolis-based Vortek Surgical LLC will relocate to Brownsburg, expanding its headquarters, manufacturing and distribution
operations and creating more than 60 jobs in the next three years.
MoreBioanalytical Systems reports quarterly loss
February 17, 2010
Bioanalytical Systems Inc., a West Lafayette-based life sciences contract research firm, on Wednesday reported a loss of $1.4
million for its fiscal first quarter.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
It's also across the street from Fogo de Chao and Morton's....
Yep, the haters are trying to make good news bad. I guess it is hard to get people to believe the series is dying when they are gaining new sponsors.
David Copperfield! I remember watching his specials on TV when I was little.
Don't forget this is next to an MMA gym, a pawn shop, and some abandoned spaces.
Good project for Zionsville - A group who has owned the property for many years has waited and worked patiently to bring highest and best use development to a major corridor, and mix that in with the great downtown you have. Win Win. All the Best to Pittman Partners and Zionsville.